Her2 Ile655Val polymorphism and its association with breast cancer risk: an updated meta-analysis of case-control studies.

doi:10.1038/s41598-018-25769-y

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Her2 Ile655Val polymorphism and its association with breast cancer risk: an updated meta-analysis of case-control studies.

Scientific reports - 9 May 2018

Krishna B Madhu, Chaudhary Sanjib, Panda Aditya K, Mishra Dipti Ranjan, Mishra Sandip K

Abstract excerpt

Breast cancer (BC) is one of the most common types of cancer in women worldwide. Several factors including genetic and environmental have been linked with susceptibility to development of BC. Her2 is a transmembrane protein with tyrosine kinase activity, overexpressed in several cancers including BC. Various studies in different populations have shown association of Her2 variants with susceptibility to BC,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Case-Control Studies
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Single Nucleotide

Share to Receptor, ErbB-2

Source

Open in PubMed Open full text

Identifiers

PMID: 29743533
DOI: 10.1038/s41598-018-25769-y
PMCID: PMC5943262

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.